Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients (ANTHICUS)

AstraZeneca

Status: Completed

Conditions: Infection in ICU

Study type: Observational

Funder types: Industry

Identifiers

NCT00543894

SRP-HB-MER-2005/1

Details and patient eligibility

About

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS).

Enrollment: 500 patients

Sex

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with hospital-acquired infections and hospitalised in the ICU at one moment of their hospital stay

• Hospital-acquired infections accounting for eligibility are:

  • nosocomial pneumonia (including ventilator-associated pneumonia)
  • bacteremia
  • intra-abdominal infections
  • urosepsis